Herber et al. showed that, in the MRL-Faslpr mouse model of SLE, blocking IL-21 with IL-21R-Fc reduced renal disease lymphadenopathy, skin lesions, and circulating autoantibodies and IgG [26]. Here, IL21 is linked to systemic lupus erythematosus.